ArticleCureus2025

In Silico Redesign of Epstein-Barr Virus Entry Glycoproteins to Redirect Cellular Tropism as a Foundation for a Novel B Cell Oncolytic Therapy.

Jeevpreet Ahluwalia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.